Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Mohsen Moghadami and Amirhossein Erfani.
Mohsen Moghadami
Connection Strength
0.340
Amirhossein Erfani
  1. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis. 2020 Jun 18; 20(1):427.
    View in: PubMed
    Score: 0.222
  2. Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021 May 11; 21(1):436.
    View in: PubMed
    Score: 0.059
  3. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021 04 10; 21(1):337.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.